ArticleJournal for immunotherapy of cancer2022

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade.

Lijun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.